Qiuming Zeng

Qiuming Zeng's research focuses on autoimmune and inflammatory neurological disorders, including multiple sclerosis, neuromyelitis optica spectrum disorder, myasthenia gravis, and autoimmune encephalitis. Much of the work involves clinical studies evaluating treatments such as plasma exchange, lymphoplasmapheresis, rituximab, and emerging therapies like CAR-T cells, often using retrospective or multicenter patient data from China. This research is relevant to students interested in translational and clinical neuroimmunology, particularly diagnosis and treatment outcomes for rare autoimmune neurological diseases.

Publication output has grown somewhat unevenly over the past decade, rising from about 2-5 papers per year in 2017-2020 to a higher and fairly steady pace of 6-9 papers per year from 2023-2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026